<- Go Home

Collagen Aesthetics, Inc.

As of September 1, 1999, Collagen Aesthetics, Inc. was acquired by Allergan Medical. Collagen Aesthetics, Inc. is engaged in the design, development, manufacture, and marketing of biomedical devices for the treatment of defective, diseased, traumatized or aging human tissues. The company's products are used principally in facial aesthetic applications and the treatment of stress urinary incontinence. The company markets its facial aesthetic products directly and through a network of international distributors, and its stress urinary incontinence product through a marketing partner. The company is based in Palo Alto, California.

Market Cap

$138.6M

Volume

35.4K

Cash and Equivalents

$15.8M

EBITDA

-$4.9M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$56.8M

Profit Margin

69.83%

52 Week High

$16.31

52 Week Low

$7.25

Dividend

N/A

Price / Book Value

1.31

Price / Earnings

37.73

Price / Tangible Book Value

1.48

Enterprise Value

N/A

Enterprise Value / EBITDA

N/A

Operating Income

-$11.1M

Return on Equity

3.16%

Return on Assets

-3.99

Cash and Short Term Investments

$18.3M

Debt

N/A

Equity

$110.7M

Revenue

$81.4M

Unlevered FCF

-$1.1M

Sector

Health Care Equipment and Supplies

Category

N/A

Company Stock Pitches